Insulin-like growth factor-I (IGF-I) stimulates the production of extracellular matrix by cartilage cells and this action is mediated through the Type 1 IGF receptor. Expression of the genes for the IGF receptor and for IGF-I was examined in normal and osteoarthritic (OA) human articular cartilage by in situ hybridization. RNA transcripts for Type 1 receptor were detected in all 73 tissue samples and in 80-100% of chondrocytes per section. Signal for the receptor was present in normal and OA cells, and the highest message levels were in the tissues exhibiting advanced pathology. Strong message signals in the ceUs of the more advanced lesionS were also noted for IGF-I, whereas little or no IGF-I mRNA was 
Introduction
Articular cartilage consists of chondrocytes embedded in an extensive extracellular matrix. These cells synthesize, organize, and regulate the deposition of their surrounding matrix, and in normal mature tissue they actively maintain a stable equilibrium between synthesis and degradation of matrix molecules. In disease states such as osteoarthritis (OA), the stable equilibrium is disrupted, leading eventually to complete loss of cartilage from the joint surface. Reports of altered phenotypic expression in human OA chondrocytes include production of Type 111 and Type X collagen (I), the detection of novel chondroitin sulfate epitopes attached to aggrecan (2), progressive loss of extracellular matrix, and the formation of clonal cell clusters in depleted regions (3).
Insulin-like growth factors (IGFs) or somatomedins regulate the growth and differentiation of a variety of tissues and are implicated in their hypertrophy and repair (4). They was considered to be mainly produced in the liver and to mediate the actions of growth hormone on target tissues (endocrine function). However, it is now clear that IGFI is synthesized by many cells of mesenchymal origin in different tissues, indicating a local function involving autocrinelparacrine mechanisms. IGFI is a major anabolic growth factor in the regulation of articular cartilage metabolism in vitro (6,7). It also stimulates the growth of epiphyseal cartilage in vivo (8). Rat epiphysial chondrocytes express the IGF-I gene, and locally produced IGFI is implicated in stimulating clonal expansion of these cells (9). In a previous study we showed that chondrocytes in human articular cartilage also express IGFI mRNA. Very low amounts were detected in normal samples, whereas enhanced levels, four-to fivefold higher, were evident in cells from OA cartilage that had formed clusters at fibrillated sites (10). The metabolic and mitogenic action of IGFs are believed to be mediated largely through interaction with the Type 1 IGF receptor (11). Using radioligand binding and covalent crosslinking experiments, the Type 1 receptor has been demonstrated on human articular chondrocytes (12) and in mouse articular cartilage by confocal microscopy (13).
Growth factors and cytokines are implicated in the regulation of the changes that occur in OA. However, little is known about the in vivo expression of these mediators and their receptors and about whether expression is altered in the disease. In the present 133 study we examined the distribution and level of expression of the Type 1 IGF receptor gene in normal and OA human articular cartilage by in situ hybridization. This distribution was related to that of ligand IGFI. To directly compare expression of an anabolic growth factor with a degradative cytokine, we also examined the presence of interleukin-lp (ILlP) mRNA, as well as IL-6 mRNA in OA human cartilage.
Materials and Methods
Tissue Source and Preparation. A total of 35 blocks (~5 mm x 5 mm x cartilage thickness) of OA femoral head articular cartilage were taken from different regions of the joints of nine individuals aged 62-76 years after total joint replacement operations. OA blocks were sampled from the superior surface of the joint adjacent to regions of total cartilage loss and from the inferior surface that was macroscopically intact. A total of 32 blocks of age-matched cartilage were taken from 10 individuals aged 61-86 years after femoral neck fracture operations. Six blocks of normal young adult femoral articular cartilage were also obtained from a 24-year-old at an osteosarcoma operation and from a 26-year-old trauma case. In the case of age-matched and young joints, the same sites as those described for OA tissue were sampled. For each probe or antibody used, at least 50 cells per sample were examined. Of the 21 patients studied, 11 were receiving nonsteroidal anti-inflammatory drugs before surgery. In all experiments described in this study, no difference was observed between the results obtained from individuals on medication compared with those not on medication.
Preparation of Probes. For IGF-I, the Type 1 IGF receptor, and IL6, in situ hybridization was performed using in vitro synthesized RNA la- between the rat and human Type 1 receptor DNA sequences. Human IL6 cDNA was a gift of Dr. L. T. May et al. (18) . IGF receptor and IL6 cDNAs had been subcloned into pGEM and pSPT 18 vectors. After linearization, antisense and sense cRNA was transcribed using SP6 and T7 promoters. The template DNA was removed by RNAsefree DNAse I (Pharmacia; Freiburg, Germany) and the RNA probes were purified by ethanol precipitation.
In Situ Hybridization. Cryostat sections 6 pm thick were cut at -40°C and thaw-mounted onto 3-aminopropyltriethoxysilane-treated slides prepared as described by Tourtellotte et al. (19) . Sections were fixed in 4% paraformaldehyde, washed in PBS, and stored at -70°C until used. Tissue sections were pcrmeabilized in 0.3% Triton X-100 in PBS for 15 min and digested in 10 pg/ml pronase (in 10 mM Tris-HC1, pH 8.0, 50 mM E V A ) for 30 min at 37°C. Slides were immersed in 0.1 M glycine in PBS for 5 min, postfixed with 4% paraformaldehyde in PBS for 3 min, and rinsed in PBS. Sections were acetylated for 10 min in freshly prepared 0.1 M triethanolamine (pH 8.0) containing 0.25% (vlv) acetic anhydride. rinsed in DEPC-water. and air-dried. 3'S-labeled RNA was heated to 80°C for 30 sec, then cooled on ice, and hybridization was performed under siliconized glass coverslips in 40% formamide, 10% (wlv) dextran sulfate, 200 pg total yeast RNAlml, 8 mM dithiothreitol, 35S-labeled RNA (-3 ngkection; specific activity 5 x 10' dpm/Clg) and "salts" [3 M NaCI, 0.1 M Tris-HCI, 0.1 M Nap04 (pH 6.8), 50 mM EDTA, 0.2% (wlv) Ficoll400, 0.2% (wlv) polyvinylpyrrolidone 360,000, 0.2% (wlv) BSA fraction VI at 50% for 18 hr in a humidified chamber. For posthybridization washing, coverslips were removed in 2 x SSC and sections washed in fresh solution for 15 min at room temperature (RT). Slides were treated with 20 pglml RNAse A (Sigma; Poole, UK) in 2 x SSC for 30 min at 37°C to remove nonhybridized singlestranded RNA. Sections were washed in 2 x SSC for 30 min at RT, then twice in 0.1 x SSC for 30 min at 65°C. Tissue was then dehydrated in an ethanol series and air-dried. Throughout posthybridization, 10 mM 2-mercaptoethanol was included in SSC solutions. Autoradiography was for 14 days using K5 emulsion (Ilford; London, UK) and sections were observed unstained or stained with toluidine blue or hematoxylin and eosin.
Interleukin-1 expression was examined using a 30mer oligonucleotide probe cocktail recognizing exons 5,6, and 7 of the human ILlp gene (British Biotechnology; Abingdon, UK). The probe had been digoxygenin-labeled and hybridization was detected with an alkaline phosphatase antibody conjugate with substrates 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium (method as described in British Biotechnology's standard protocol).
Quantitation of IGF Receptor In Situ Hybridization. Sections were examined blind by the investigator using a code known only by a colleague. A random high-power field was selected and the cell situated closest to the center of the field was measured first; the next closest cell was then measured, and so on. The cartilage blocks that were sampled are described above. Quantitation of autoradiographs was performed with an image archiving system linked to a Nikon light microscope. The percentage of black pixels overlying a chondrocyte was determined and, using the same sample area, an adjacent region with no cells was counted to obtain a background reading. The background value was then subtracted from the chondrocyte value.
Immunohistochemistry. Cryostat sections (6 pm thick) were cut from the same cartilage as that used for in situ hybridization. Sections were fixed in 4% paraformaldehyde for 30 min, placed in blocking buffer (1% BSA in PBS) for 15 min, and treated with 25 pI of antihuman IGF-I polyclonal antibody (diluted 1:200 in blocktng buffer) or antihuman Type 1 IGF receptor monoclonal antibody (diluted 1:50 in blocking buffer) for 45 min. After washing and blocking as above, sections were incubated for 30 min in 25 pl biotinylated goat antirabbit or antimouse IgG (Sigma) diluted 1:250 in blocking buffer. After a further wash and blocking step, sections were treated for 30 min with 2.5 pglml streptavidin-peroxidase (Sigma) in 0.1 M Tris-HCI (pH 7.6) containing 1% BSA. The sections were washed with 0.1 M Tris-HC1, pH 7.6, for 2 min and then treated with substrate (0.5 mglml diaminobenzidine in Eis-HCI and 0.01% H202) for 15 min. After a final wash with Tris-HCI followed by distilled water, sections were mounted in Apathy's medium and viewed by Nomarski interference microscopy.
The IGF-I polyclonal antibody binds IGF-I specifically and has 0.5 % crossreactivity with IGF-11, and crossreacts minimally with insulin at molar (20, 21) . The antibody was a gift from Drs. L. Underwood and J . van Wyk, and is distributed by the Hormone Distribution Program of NIDDK (Bethesda. MD). Three monoclonal antibodies specific for the human Type 1 IGF receptor were used: 24-60, 24-57, and 26-3. These were kindly supplied by Dr. K. Siddle (Dept. of Clinical Biochemistry. University of Cambridge, UK). The antibodies bind to epitopes on the extracellular portion of the receptor and do not react with human insulin receptors or rat Type 1 receptors (22) . Control experiments were performed in which the primary antibody was omitted, replaced with an isotype-matched control IgG in the case of IGF receptor antibodies, or replaced with nonimmune rabbit serum in the case of the IGF-I antibody.
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. I surface, yet without the presence of cell clones (4 on the Mankin scale of OA; 23). and more advanced fibrillation characterized by deeper clefts, cartilage thinning. and the presence of cell clones (8 on the Mankin scale). in moderate and severe OA tissue the normal zonal classification is not possible because of cartilage loss. Therefore, cartilage in these regions was categorized as follows: surface layer, <150 pm from the surface, and deeper layer, >150 pm from the surface. 
Results

Tissue Sampling
Histological examination of articular cartilage from young individuals showed it to be normal, with a smooth intact surface and the characteristic arrangement of superficial, mid-and deep layers (or zones). Cartilage taken from macroscopically normal regions of OA joints and age-matched joints was essentially similar to young cartilage, being full thickness and having an intact surface and a normal arrangement of chondrocytes. Some of the age-matched joints contained subclinical OA lesions and were not included in this study. Cartilage sampled from OA lesions adjacent to regions of total cartilage loss was classified into two categories of severity: moderate fibrillation with superficial splitting and fraying of the articular
Type 1 IGF Receptor: In Situ Hybridization and Immunoloculizution
Sections of human articular cartilage were incubated with antisense and sense [3'S]-RNA probes. The antisense probe hybridizes specifically to IGF receptor mRNA, whereas the sense probe is a control and indicates nonspecific binding. Using the antisense probe, receptor message was detected in all samples of articular cartilage (Figure 1 ) and signal was apparent in all cartilage layers. Little or no signal was evident using the sense probe. The numbers of autoradiographic grains overlying cells were quantitated by image analysis after background subtraction. The percentage of positive cells was counted and was scored as positive when the signal intensity using the antisense probe was greater than that using the sense probe. A high proportion of normal and OA chondrocytes, between 80 and 100% (n = 260). contained receptor message.
The level of receptor message within chondrocytes is shown in Figure 2 . A relatively strong signal was found in all cartilage samples, and there was no significant difference in the amount of grains per cell in moderate lesions compared to normal regions of OA joints and age-matched tissue. However, a significantly higher signal intensity was apparent in more advanced lesions compared to all samples of normal cartilage @<0.05). Data were expressed as variation with cartilage depth (Figure 3) . The highest level of message was in the surface cells of more advanced lesions, where the signal intensity was approximately 1.5-fold higher than that of agematched cartilage. For all tissues there was no significant variation in the amount of grainskell with cartilage depth. To investigate whether the receptor mRNA was translated, sections were treated with monoclonal antibodies to the human Type 1 IGF receptor protein. In all cartilage samples in which chondrocyres stained positively for the IGF receptor, the distribution of immunoreactivity was at the membrane, including cell processes, and cytoplasmic (Figure 4) . Approximately 60-80% of chondrocytes (n = 1730) stained positively for the receptor, and staining was present throughout the depth of normal and fibrillated OA cartilage. In all regions where the Type 1 receptor mRNA was detected by in situ hybridization, the receptor protein was demonstrated by immunohistochemistry, suggesting that the message was translated.
An identical pattern of staining was observed with 26-3.24-60. and 24-57 monoclonal antibodies, whereas the intensity of staining was consistently less in the case of 24-57. Immunoreactivity was absent in control experiments in which the primary antibody was omitted or when the primary antibody was replaced with an isotypematched control. and intracellular staining was observed in the cartilage of all individuals examined (Figures 5F-51) . Immunoreactivity was present throughout the depth of cartilage samples, with 55-951 of cells (n = 1520) scoring positive. The lowest percentage of stained cells were the discoid chondrocytes of the superficial zone of normal tissue and the highest percentage was in the surface layer of more advanced lesions, where a high proportion of cell clones occurred.
Some extracellular staining was detected ( Figures 5G and 51) , and this IGF-I was present in two locations: pericellularly or territorially around the chondrocytes, and within the surface matrix. Extracellular growth factor may be bound to IGF binding proteins, which are known to be produced by articular chondrocytes in vitro (24) . Alternatively growth factors may bind to matrix components such as proteoglycans (25). Intracellular and extracellular staining was absent in control experiments in which the primary antibody was omitted or substituted with nonimmune rabbit serum.
I L l p and IL-6 In Situ Hybridization
LPS-stimulated human monocytes were used as a positive control to test for IL-lD expression using a digoxygenin-labeled oligonucleotide probe. Monocytes stained strongly, showing the presence of abundant message ( Figure 6A ). ILlD expression in cartilage was examined in 17 OA samples from five individuals, 14 samples from four aged-matched joints, and three samples from a normal young individual. IL-lD mRNA was detected in cartilage from only one OA joint. In this patient, staining occurred in a region of moder-
IGF-I In Situ Hybridization and Immunolocalization
In our previous study we described IGF-I mRNA expression in human articular cartilage (10). IGF-I expression has been included here for several reasons. First, to more precisely compare IGF receptor expression with its ligand, the same cartilage samples were examined for the expression of both genes. Second, a wider range of OA samples from different patients is presented here, together with age-matched cartilage included as a control.
With the antisense probe, IGF-I mFWA was detected in moderate and more advanced OA lesions, particularly in cell clusters, whereas there was little or no signal in histologically normal regions of OA cartilage, age-matched, and young tissue (~i~~~~~ 5~-5~) , Sections adjacent to those processed for in situ hybridization were immunolabeled with a polyclond antibody specific for IGFI (20,21), Little or no mRNA signal is apparent in (A) normal young cartilage, (E) age-matched cartilage, and (C) histologically normal cartilage from OA joints. However, a strong message signal is present in the cell clusters of (D) cartilage from OA lesions. A-D show the results using the antisense probe and E is an OA cell clone using the sense probe. All of these sections were stained with hematoxylin and eosin except for C. which was stained with toluidine blue. Intracellular IGF-1 protein localizes in the superficial zone of normal young cartilage (F), in the midzone of histologically normal OA cartilage (G). and in a cell clone from an osteoarthritic lesion (H). Reduced staining intensity is apparent in the superficial discoid cells of normal cartilage (F). Some extracellular staining (arrows) is apparent pericellularly (G) and at the articular surface in a region of fibrillation (I). Bar = 20 pm.
ate fibrillation where 39-45% (n = 370) cells were positive (Figure 6B) . Chondrocytes from the remaining four OA patients were completely negative for IL-1(3 mRNA signal ( Figure 6C) . None of the age-matched control cartilage showed positive staining. However, in the young normal cartilage IL-lP mRNA was detected in the superficial chondrocytes ( Figure 6D ). Cells from deeper zones were negative. Sections that had been treated with RNAse A (20 Wglml for 30 min at 37'C) before hybridization were negative.
Sixteen samples of articular cartilage from four OA patients and three samples from normal young adult individuals were examined for IL-6 message. With an antisense RNA probe, signal for IL6 mRNA was present in fibrillated OA cartilage both in surface and in deep cells (Figures 6E and 6F ). where the signal was weaker than that of IGF receptor and IGF-I. IL-6 mRNA was not detectable in histologically normal regions of OA joints and in normal young adult cartilage ( Figure 6G ). With the sense RNA probe, signal was absent in all samples examined.
Discussion
This study shows that human articular chondrocytes express the Type 1 IGF receptor gene in situ at the mRNA and protein level. The message signal is present throughout the normal and OA cartilage and is strongest in the more advanced lesions of OA samples. This pattern of expression correlates with that shown by IGF-I mRNA. where maximal levels of message also occur in the cells of more advanced lesions. The magnitude of increase in OA receptor mRNA signals was l.S-fold, which is less marked than that of IGF-I (4-5 fold) (10). This difference implies divergent transcriptional control of the two genes, but because steady-state levels of mRNA depend on both gene transcription and mRNA stability, the exact mechanism responsible for these changes remains to be elucidated. Our in situ results are in line with binding studies on extracted human chondrocytes that show a significant increase in IGF-I binding sites in OA compared to normal cells (12).
Differences were apparent between the in situ hybridization and immunohistochemical data for IGF-I. In histologically normal samples, little or no IGF-I mRNA was detected, whereas IGF-I protein could be demonstrated associated with cells and the matrix. These results suggest that in normal articular cartilage a predominant source of the growth factor may be from exogenous sources rather than that produced by the chondrocytes themselves, which is in agreement with the results obtained from cultured normal bovine articular cartilage (26) . This situation probably changes in OA cartilage, in which the proportion produced by the chondrocytes may increase and locally produced IGF may therefore increase in functional importance.
Several possible regulatory mechanisms could be responsible for the higher levels of IGF-I mRNA expression on OA lesions. These include penetration of stimulatory mediators from the synovial fluid, local production of mediators, or mechanical factors. In the former case, circulating levels of growth hormone are reported to increase in OA individuals (27) . Therefore, the upregulation in IGFI expression by OA chondrocytes may be regulated, at least in part, by a growth hormone-dependent mechanism. In this context, growth hormone is known to stimulate local IGF-I synthesis by rat growth plate chondrocytes (28) .
Increased expression of IGF receptor and IGF-I ligand by OA chondrocytes may be involved in mediating some of the changes that occur during cartilage degeneration. One of the features of human OA is that the chondrocytes undergo enhanced DNA synthesis and frequently proliferate into cell clusters (3, 23) . This is in contrast to normal adult cartilage, in which cells rarely divide. IGF-I is known to have mitogenic effects on normal articular chondrocytes in culture (24, 29) where it is suggested that endogenously produced IGF-I may stimulate proliferation (24) . In the present study, the highest expression of IGF-I and its receptor was in the chondrocytes of more advanced lesions, where a high proportion of cell clusters occur. This finding suggests that IGF-I may be involved in signaling chondrocyte cluster formation in OA cartilage.
In OA human cartilage there is a marked induction of Type I1 collagen "A, as shown by in situ hybridization (30) . This dlffers from normal adult articular cartilage, which shows much less Type I1 collagen message. Metabolic studies show enhanced collagen synthesis in human OA cartilage, as demonstrated by [ 3H]-proline incorporation (31) . IGF-I is known to enhance collagen synthesis by normal rabbit articular chondrocytes (32) . In addition, more recent metabolic studies show enhanced Type 11, E, and XI collagen synthesis by chick sternal chondrocytes in response to IGFI (29) . In this culture system, IGFI does not stimulate Type X collagen synthesis and chondrocyte hypertrophy. Therefore, enhanced IGF receptor and IGF-I production in OA cartilage may signal the increased Type I1 collagen expression.
The OA phenotype is believed to represent a reparative response to the focal depletion of matrix components (1). Therefore, expression of IGF receptor and ligand genes by OA chondrocytes may be involved in mediating attempted repair and remodeling. A role for IGF-I in the replacement of damaged matrix in cartilage is in agreement with data from other tissues. In nerves, muscle, skin, and kidney, locally produced IGFI has been strongly implicated in the response to tissue injury, where the growth factor is involved in regenerative growth and dlfferentiation (33) .
IL-1 is a pro-inflammatory cytokine with a potential role in the pathogenesis of OA (34) . The mediator is a potent stimulator of proteoglycan degradation and an inhibitor of proteoglycan synthesis in cartilage explants, leading to rapid net depletion of this matrix molecule (35) (36) (37) . In addition, IL1 has been detected in the synovial fluid from patients with OA (38) (39) (40) . IL1 mRNA has also been demonstrated in isolated human articular chondrocytes from one individual (41) and in cultured rabbit chondrocytes (42). In the present study we were interested in relating autocrine ILlp production by chondrocytes in situ with the severity of OA cartilage lesions, but were able to detect ILlp message only in a minority of OA cartilage samples. Similarly, IL1 message was demonstrated in some normal cartilage samples. These results show a lack of correlation between chondrocyte IL1p expression and the development of lesions in OA cartilage. Within the sensitivity of the technique, this suggests that there is minor involvement of autocrine IL-@ in mediating OA matrix depletion or that IGlp is very transiently expressed, and we were unable to detect this expression at the time of tissue sampling. These data are in accord with the in situ hybridization study of Dodds et al. (43) , who showed no ILlp mRNA in the chondrocytes of osteophytes from human OA joints.
IL-1 protein has been demonstrated in chondrocytes of human OA cartilage by immunohistochemistry (44,45), and our results agree with those of Pelletier and Martel-Pelletier (46), who showed that only a minority of human OA cartilage (two samples out of eight) were positive for intracellular IL-1 protein. However, more abundant IL-1 protein and mRNA have been demonstrated in inflamed synovium, both in OA and rheumatoid samples (46,47). It is now clear that infiltrates of mononuclear cells are commonly found in OA synovial membranes, even in patients with early disease (48, 49) . This implies that a synovial source of the cytokine is likely to be more significant than that originating from cartilage, in terms of potential contribution to OA pathology.
IL6 is a pleiotropic cytokine that is implicated as a mediator in arthritic disease. It is produced by human articular chondrocytes in culture (50, 51) . In the present study, signals for IL6 message were demonstrated in situ within the chondrocytes of fibrillated OA cartilage, whereas signals were absent in histologically normal samples. Chondrocytes positive for IL6 protein have been found in OA cartilage by immunohistochemistry (43). Our findings suggest that this protein originates, at least in part, from autocrine production by the chondrocyte itself. Because IL-6 is known to be mitogenic to human OA chondrocytes ( 5 2 ) , the expression of IL6 in fibrillated cartilage may help to mediate the increased cell proliferation that occurs in OA cartilage. In this context, IL6 and IGF-I could be acting additively or synergistically.
IL-6 is not an effective inhibitor of cartilage proteoglycan synthesis alone (53) . However, one study using cultured human cartilage showed that IL1-induced IL6 production is required for inhibition of proteoglycan synthesis by IL1 (54) . Therefore, IL6 expression by OA chondrocytes in vivo may enhance the ability of IL-1 to induce inhibition of proteoglycan synthesis, leading to increased matrix depletion and disease progression. Although it is conceivable that a synovial source of IL-6 might also be involved in such IL-1-mediated inhibition of proteoglycan synthesis, this may well not be the case, because hardly any IL-6 was detected in OA synovial fluid (54) . Therefore, locally produced IL6 may be more significant in this respect.
